Search results
Kapitalo Investimentos Ltda Purchases 130 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 16 hours agoKapitalo Investimentos Ltda increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 118.2% in the fourth quarter, according to its most recent ...
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 5 days agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Congress Asset Management Co. MA Has $504,000 Holdings in Becton, Dickinson and Company (NYSE:BDX)
ETF DAILY NEWS· 18 hours agoCongress Asset Management Co. MA trimmed its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 41.5% in the fourth quarter, according to its ...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 5 days agoVertex Pharmaceuticals has reported long-term data for its gene therapy Casgevy (exa-cel) in...
Why Bernie Sanders’ Ozempic crusade is misguided
Dallas Morning News· 2 days agoIt’s not surprising that Sanders, one of the most vociferous critics of the pharmaceutical industry in Congress, would take such a critical approach.
Congress Asset Management Co. MA Sells 1,209 Shares of Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 2 days agoCongress Asset Management Co. MA cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.9% during the 4th quarter, according to the company in its most ...
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' - NVIDIA...
Benzinga· 2 days agoOn CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals...
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update
ETF DAILY NEWS· 4 days agoAcurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling ...
Community pharmacists join the PBM ad frenzy
Politico· 2 days agoPCMA is...
EHA 2024: AstraZeneca’s Calquence plus chemoimmunotherapy offers new standard for MCL
Pharmaceutical Technology via Yahoo Finance· 2 days agoAnother next-generation BTK inhibitor competitor to watch for, as first-to-market Imbruvica has lost...